查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566954

封闭系统药物转移装置市场：按类型、组件和最终用户分类：2024-2033 年全球机会分析和产业预测

Closed System Drug Transfer Device Market By Type , By Component By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3个工作天内

价格
简介目录

封闭系统药物转移装置（CSTD）市场

2023年，封闭系统给药装置（CSTD）市值为8亿美元，预计2024年至2033年复合年增长率为15.7%，到2033年将达到36亿美元。

封闭系统药物转移装置（CSTD）是医疗设备。 CSTD 可防止环境中的污染物进入医疗设备和系统，并避免危险化学物质和蒸气从系统进入外部环境。这些设备对于保护患者和医护人员免受潜在细胞毒性和致畸剂的侵害至关重要。

随着癌症和其他慢性病的盛行率不断增加，CSTD 的采用在大多数医疗机构中已变得至关重要，从而推动了市场的成长。此外，职业安全与健康管理局和美国药典等多个管理机构的监管执法正在推动对 CSTD 的需求。 CSTD 与自动化和机器人技术的整合是一种趋势，在药房和配药设施中受到广泛关注，以确保危险化学品的高效处理和使用。

然而，CSTD 与各种尺寸的注射器、管瓶和输液系统的兼容性相关的技术障碍带来了故障风险，并阻碍了封闭系统药物输送装置 (CSTD) 市场的开拓。此外，CSTD 的使用需要高熟练度和专门培训，并且通常是资源集中和劳动力密集型的。这阻碍了市场的成长。相较之下，癌症患者的快速增加预计将为市场提供利润丰厚的成长机会。到 2040 年，癌症患者数量预计每年增加 3,000 万，医院需要使用 CSTD。

按部门审查

封闭系统药物转移装置 (CSTD) 市场按类型、组件、最终用户和区域进行细分。按类型划分，市场分为膜对膜式和无针式。依成分分为屏障型CSTD和空气清净机CSTD。依最终使用者分类，可分为医院/诊所、肿瘤中心等。从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲地区进行了分析。

主要发现

按类型划分，膜到膜细分市场主导封闭系统药物转移装置 (CSTD) 市场。

从最终用户来看，医院和诊所占据了很大的份额。

按地区划分，北美是封闭系统给药装置（CSTD）市场的主要收益来源。

该报告可以定制。

  • 监管指引
  • 根据客户兴趣新增其他公司简介
  • 平均售价分析/价格分布分析
  • 历史市场资料
  • 赎回场景

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章封闭系统药物转移装置（CSTD）市场：依类型

  • 市场概况
  • 膜对膜
  • 无针

第五章封闭系统药物转移装置（CSTD）市场：依组成部分

  • 市场概况
  • 屏障型CSTD
  • 空气净化CSTD

第六章 封闭系统药物转移装置（CSTD）市场：依最终使用者分类

  • 市场概况
  • 医院和诊所
  • 肿瘤中心
  • 其他的

第七章 封闭系统给药装置（CSTD）市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国封闭系统给药装置（CSTD）市场
    • 加拿大封闭系统给药装置（CSTD）市场
    • 墨西哥封闭系统药物转移装置（CSTD）市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国封闭系统药物转移装置（CSTD）市场
    • 德国封闭系统药物转移装置（CSTD）市场
    • 义大利封闭系统药物转移装置（CSTD）市场
    • 西班牙封闭系统药物转移装置（CSTD）市场
    • 英国封闭系统药物转移装置（CSTD）市场
    • 其他欧洲国家封闭系统药物转移装置 (CSTD) 市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国封闭系统药物转移装置（CSTD）市场
    • 日本封闭系统药物转移装置（CSTD）市场
    • 印度封闭系统给药装置（CSTD）市场
    • 韩国封闭系统药物转移装置（CSTD）市场
    • 澳洲封闭式给药装置（CSTD）市场
    • 其他亚太地区封闭式给药装置 (CSTD) 市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西封闭系统药物转移装置（CSTD）市场
    • 南非封闭系统药物转移装置（CSTD）市场
    • 沙乌地阿拉伯封闭系统药物转移装置（CSTD）市场
    • 其他拉丁美洲/中东/非洲封闭系统药物转移装置 (CSTD) 市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • B. Braun Holding GmbH And Co. KG
  • Baxter International
  • Becton, Dickinson And Company
  • Caragen Ltd.
  • Corvida Medical
  • Equashield
  • FIMI Opportunity Funds（Simplivia Healthcare）
  • ICU Medical
  • JCB Co Ltd.
  • Yukon Medical
简介目录
Product Code: A324072

Closed System Drug Transfer Device (CSTD) Market

The closed system drug transfer device (CSTD) market was valued at $0.8 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 15.7% from 2024 to 2033.

A closed system drug transfer device (CSTD) is a medical equipment which prevents contact between the inner environment of a system and the outer surroundings. CSTD forbids the entry of contaminants from the surroundings into medical equipment or system and prohibits the evasion of hazardous chemicals or vapors from the system to the external environment. These devices are critical for the safety of both patients and the medical professionals working in a hospital setting from probable cytotoxic or teratogenic agents.

With increasing prevalence of cancer and other chronic diseases, the adoption of CSTD is becoming essential in most healthcare settings, hence driving the growth of the market. In addition, implementation of regulatory mandates by several governing bodies such as Occupational Safety and Health Administration and the United States Pharmacopeia is boosting the demand for CSTDs. The integration of CSTDs with automation & robotics is a trend gaining significant prominence in pharmacies and drug preparation facilities to ensure efficient handling and usage of hazardous chemicals.

However, technical hurdles associated with the compatibility of CSTDs with diverse sizes of syringes, drug vials, and infusion systems pose the risk of malfunctions and hamper the development of the closed system drug transfer device (CSTD) market. Moreover, the usage of CSTDs requires high proficiency and specialized training, which is usually resource-intensive and laborious. This hampers the market growth. Contrarily, the exponentially rising cases of cancer are anticipated to present lucrative growth opportunities for the market. The number of cancer cases are expected to increase at the rate of 30 million new cases per year by 2040, thereby necessitating the use of CSTDs in hospitals.

Segment Review

The closed system drug transfer device (CSTD) market is segmented into type, component, end user, and region. On the basis of type, the market is bifurcated into membrane to membrane and needleless. Depending on component, it is divided into barrier type CSTDs and air cleaning CSTDs. As per end user, it is categorized into hospitals & clinics, oncology centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the membrane to membrane segment dominates the closed system drug transfer device (CSTD) market.

As per end user, the hospitals & clinics segment holds a high share of the market.

Region wise, North America is the major revenue generator of the closed system drug transfer device (CSTD) market.

Competition Analysis

The key players operating in the global closed system drug transfer device (CSTD) market include B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd., Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd., and Yukon Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Average Selling Price Analysis / Price Point Analysis
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Component

  • Barrier type CSTDs
  • Air cleaning CSTDs

By End User

  • Hospitals and Clinics
  • Oncology Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

By Type

  • Membrane to membrane
  • Needleless

Key Market Players:

    • B. Braun Holding GmbH & Co. KG
    • Baxter International
    • Becton, Dickinson and Company
    • Caragen Ltd.
    • Corvida Medical
    • Equashield
    • FIMI Opportunity Funds (Simplivia Healthcare)
    • ICU Medical
    • JCB Co Ltd.
    • Yukon Medical

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Membrane To Membrane
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Needleless
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Component
  • 5.2. Barrier Type CSTDs
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Air Cleaning CSTDs
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals And Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Oncology Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Component
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Closed System Drug Transfer Device (CSTD) Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Component
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Closed System Drug Transfer Device (CSTD) Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Component
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Closed System Drug Transfer Device (CSTD) Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Component
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Component
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Closed System Drug Transfer Device (CSTD) Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Component
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Closed System Drug Transfer Device (CSTD) Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Component
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Closed System Drug Transfer Device (CSTD) Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Component
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Closed System Drug Transfer Device (CSTD) Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Component
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Closed System Drug Transfer Device (CSTD) Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Component
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Closed System Drug Transfer Device (CSTD) Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Component
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Component
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Closed System Drug Transfer Device (CSTD) Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Component
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Closed System Drug Transfer Device (CSTD) Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Component
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Closed System Drug Transfer Device (CSTD) Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Component
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Closed System Drug Transfer Device (CSTD) Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Component
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Closed System Drug Transfer Device (CSTD) Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Component
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Closed System Drug Transfer Device (CSTD) Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Component
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Component
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Closed System Drug Transfer Device (CSTD) Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Component
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Closed System Drug Transfer Device (CSTD) Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Component
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Closed System Drug Transfer Device (CSTD) Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Component
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Closed System Drug Transfer Device (CSTD) Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Component
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. B. Braun Holding GmbH And Co. KG
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Baxter International
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Becton, Dickinson And Company
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Caragen Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Corvida Medical
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Equashield
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. FIMI Opportunity Funds (Simplivia Healthcare)
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. ICU Medical
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. JCB Co Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Yukon Medical
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments